Image Place holder

Claudia G. Berman, MD


Specialty: Radiology
Program: Diagnostic Imaging and Interventional Radiology

Call 1-888-MOFFITT
(1-888-663-3488)

or call 1-888-MOFFITT
(1-888-663-3488)

Overview

Dr Berman has been with Moffitt since 1988 having completed residency training in Diagnostic Imaging and Fellowship training in Nuclear Medicine and Magnetic Resonance Imaging.

Education & Training

Board Certification:

  • Diagnostic Radiology

Fellowship:

  • University of South Florida - Magnetic Resonance Imaging
  • University of Pennsylvania - Nuclear Medicine

Residency:

  • Mercy Catholic Medical Center, Philadelphia - Diagnostic Imaging

Medical School:

  • Jefferson Medical College, PA - MD
Participating Trials

CLINICAL TRIAL 16480
Radiomics: A Prospective Study of Outcome in Lung Cancer
Condition: Thoracic
Intervention:
Open

If you believe you are eligible for one of these trials or studies, please call
1-888-MOFFITT (1-888-663-3488).

Publications

  • Jeong D, Gage KL, Berman CG, Montilla-Soler JL. Cardiac Magnetic Resonance for Evaluating Catheter Related FDG Avidity. Case Rep Radiol. 2016 Nov;2016:5460727. Pubmedid: 27867676. Pmcid: PMC5102723.
  • Pimiento JM, Davis-Yadley AH, Kim RD, Chen DT, Eikman EA, Berman CG, Malafa MP. Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer. Clin Nucl Med. 2016 Mar;41(3):177-181. Pubmedid: 26673243. Pmcid: PMC4740191.
  • Hassani J, Porubsky C, Berman C, Zager J, Messina J, Henderson-Jackson E. Intraperitoneal Rosai-Dorfman disease associated with clear cell sarcoma: first case report. Pathology. 2016 Dec;48(7):742-744. Pubmedid: 27814905.
  • Jadvar H, Subramaniam R, Berman CG, Boada F, Colletti PM, Guimaraes A, McConathy J, Meltzer C, Noto RB, Packard A, Rohren E, Oates ME. American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Brain. J Nucl Med. 2015 Apr;56(4):642-645. Pubmedid: 25745088. Pmcid: PMC4465538.
  • Kumar V, Nath K, Berman CG, Kim J, Tanvetyanon T, Chiappori AA, Gatenby RA, Gillies RJ, Eikman EA. Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings. Clin Nucl Med. 2013 Mar;38(3):175-182. Pubmedid: 23354032. Pmcid: PMC3578161.
  • Finkelstein SE, Iclozan C, Bui MM, Cotter MJ, Ramakrishnan R, Ahmed J, Noyes DR, Cheong D, Gonzalez RJ, Heysek RV, Berman C, Lenox BC, Janssen W, Zager JS, Sondak VK, Letson GD, Antonia SJ, Gabrilovich DI. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients. Int J Radiat Oncol Biol Phys. 2012 Feb;82(2):924-932. Pubmedid: 21398051. Pmcid: PMC4241354.
  • Zager JS, Brodsky S, Berman CG. Imaging of Merkel cell carcinoma. Curr Probl Cancer. 2010 Jan;34(1):65-76. Pubmedid: 20371075.
  • Khera S, Kiluk J, Hasson D, Meade T, Meyers M, Dupont E, Berman C, Cox C. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J. 2008 May;14(3):250-254. Pubmedid: 18476883.
  • Berman CG. Recent advances in breast-specific imaging. Cancer Control. 2007 Oct;14(4):338-349. Pubmedid: 17914334.
  • Li L, Wu Z, Salem A, Chen Z, Chen L, George F, Kallergi M, Berman C. Computerized analysis of tissue density effect on missed cancer detection in digital mammography. Comput Med Imaging Graph. 2006 Jul;30(5):291-7. Pubmedid: 16837164.
  • Kallergi M, Lucier B, Berman C, Hersh M, Kim J, Szabunio M, Clark R. High-performance wavelet compression for mammography: localization response operating characteristic evaluation. Radiology. 2006 Jan;238(1):62-73. Pubmedid: 16373759.
  • Kallergi M, Berman C, Cressman J, Loeffler W, Pat Romilly A, Szabunio M, Vedam P, Venugopal P, Walker J. Clinical evaluation of a new digitizing device for improved film mammography. Acad Radiol. 2004 Nov;11(11):1242-1250. Pubmedid: 15561571.
  • Kallergi M, Heine J, Berman C, Hersh M, Romilly A, Clark R. Improved interpretation of digitized mammography with wavelet processing: a localization response operating characteristic study. Ajr Am J Roentgenol. 2004 Mar;182(3):697-703. Pubmedid: 14975972.
  • Cox C, Furman B, Stowell N, Ebert M, Clark J, Dupont E, Shons A, Berman C, Beauchamp J, Gardner M, Hersch M, Venugopal P, Szabunio M, Cressman J, Diaz N, Vrcel V, Fairclough R. Radioactive seed localization breast biopsy and lumpectomy: can specimen radiographs be eliminated?. Ann Surg Oncol. 2003 Nov;10(9):1039-1047. Pubmedid: 14597442.
  • Malhotra P, Berman CG. Evaluation of bone metastases in lung cancer. Improved sensitivity and specificity of PET over bone scanning. Cancer Control. 2002 May;9(3):254, 259-254, 260. Pubmedid: 12060823.
  • Dupont E, Kamath V, Ramnath E, Shivers S, Cox C, Berman C, Leight G, Ross J, Blumencranz P, Reintgen DS. The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol. 2001;8(4):354-359. Pubmedid: 11352310.
  • Chirikos T, Berman C, Luther S, Clark R. Cost consequences of sentinel lymph node biopsy in the treatment of breast cancer: a preliminary analysis. Int J Technol Assess Health Care. 2001;17(4):626-631. Pubmedid: 11758307.
  • Goscin C, Berman C, Clark R. Magnetic resonance imaging of the breast. Cancer Control. 2001;8:399-406. Pubmedid: 11579335.
  • Bass SS, Cox CE, Salud CJ, Lyman G, McCann C, Dupont E, Berman C, Reintgen D. The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg. 2001;192(1):9-16. Pubmedid: 11192930.
  • Kamath V, Giuliano R, Dauway E, Cantor A, Berman C, Ku N, Cox C, Reintgen D. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg. 2001;136(6):688-692. Pubmedid: 11387010.
  • Gray R, Salud C, Nguyen K, Dauway E, Friedland J, Berman C, Peltz E, Whitehead G, Cox C. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001;8(9):711-715. Pubmedid: 11597011.
  • Berman C, Clark R. Positron emission tomography in initial staging and diagnosis of persistent or recurrent disease. Curr Opin Oncol. 2000 Mar;12(2):132-137. Pubmedid: 10750724.
  • Berman C, Choi J, Hersh M, Clark R. Melanoma lymphoscintigraphy and lymphatic mapping. Semin Nucl Med. 2000 Jan;30(1):49-55. Pubmedid: 10656243.
  • Cox C, Bass S, McCann C, Ku N, Berman C, Durand K, Bolano M, Wang J, Peltz E, Cox S, Salud C, Reintgen D, Lyman G. Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med. 2000;51:525-542. Pubmedid: 10774480.
  • Smith D, Messina J, Perrott R, Berman C, Reintgen D, Cruse C, Glass F, DeConti R, Trotti A, Fenske N. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control. 2000;7(1):72-83. Pubmedid: 10740663.
  • Bass S, Dauway E, Mahatme A, Ku N, Berman C, Reintgen D, Cox C. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers <1 centimeter (T1A-T1B). Am Surg. 1999 Sep;65(9):857-861. Pubmedid: 10484089.
  • Cox CE, Bass SS, Boulware D, Ku NK, Berman C, Reintgen DS. Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol. 1999 Sep;6(6):553-561. Pubmedid: 10493623.
  • Haddad FF, Stall A, Messina J, Brobeil A, Ramnath E, Glass LF, Cruse CW, Berman CG, Reintgen DS. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol. 1999 Mar;6(2):144-149. Pubmedid: 10082038.
  • Pendas S, Dauway E, Cox C, Giuliano R, Ku N, Schreiber R, Berman C, Reintgen D. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg. 1999 Jun;65(6):500-506. Pubmedid: 10366202.
  • Kamath D, Milotes G, Lyman G, Rapaport D, Cruse C, Glass F, Fenske N, Messina J, Berman C, Reintgen D. Cutaneous lymphatic drainage in patients with grossly involved nodal basins. Ann Surg Oncol. 1999 Jun;6(4):345-349. Pubmedid: 10379854.
  • Messina J, Glass L, Cruse C, Berman C, Ku N, Reintgen D. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg. 1999 Jun;23(6):686-690. Pubmedid: 10366151.
  • Berman CG, Goscin C, Kim JJ, Miller MS. Lymphoscintigraphy in malignant melanoma and breast cancer. Surg Oncol Clin N Am. 1999 Jul;8(3):401-12, vii. Pubmedid: 10448685.
  • Brobeil A, Cruse CW, Messina JL, Glass LF, Haddad FF, Berman CG, Marshburn J, Reintgen DS. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surg Oncol Clin N Am. 1999 Jul;8(3):435-45, viii. Pubmedid: 10448688.
  • Berman CG. Radiation safety and nuclear medicine policies and procedures. Surg Oncol Clin N Am. 1999 Jul;8(3):577-81, xi. Pubmedid: 10448699.
  • Dauway E, Giuliano R, Haddad F, Pendas S, Costello D, Cox C, Berman C, Ku N. Lymphatic mapping in breast cancer. Hematol Oncol Clin N Amer. 1999 Apr;13(2):349-371. Pubmedid: 10363135.
  • Bass S, Dauway E, Mahatme A, Ku N, Berman C, Reintgen D, Cox C. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers < 1centimeter (T1A-T1B). Am Surg. 1999;65(9):857-862.
  • Shivers S, Wang X, Li W, Joseph E, Messina J, Glass L, DeConti R, Cruse W, Berman C, Fenske N, Lyman G, Reintgen D. Molecular staging of malignant melanoma: correlation with clinical outcome. Jama. 1998 Oct;280(16):1410-1415. Pubmedid: 9801000.
  • Kallergi M, Gavrielides M, He L, Berman C, Kim J, Clark R. Simulation model of mammographic calcifications based on the American College of Radiology Breast Imaging Reporting and Data System, or BIRADS. Acad Radiol. 1998 Oct;5(10):670-679. Pubmedid: 9787837.
  • Cox C, Pendas S, Cox J, Joseph E, Shons A, Yeatman T, Ku N, Lyman G, Berman C, Haddad F, Reintgen D. Guidelines for sentinel node biopsy and lymphatic mapping of breast cancer patients. Ann Surg. 1998 May;227(5):645-651. Pubmedid: 9605656.
  • Joseph E, Glass F, Glass J, Messina J, DeConti R, Cruse C, Rapaport D, Berman C, Fenske N, Reintgen D. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol. 1998 Mar;5(2):119-125. Pubmedid: 9527264.
  • Venugopal P, Berman C, Robinson L. The pleural tent: radiographic appearance. Cancer Control. 1998 Jan;5(1):41. Pubmedid: 10761016.
  • Cox C, Huddad F, Bass S, Cox J, Ku N, Berman C, Shons A, Pendas S, Reintgen D, Yeatman T. Lymphatic mapping in the treatment of breast cancer. Oncology. 1998;12(9):1283-1298. Pubmedid: 9778675.
  • Brobeil A, Berman C, Cruse C, DeConti R, Cantor A, Lyman G, Rapaport D, Joseph E, Wells K, Reintgen D. Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma. Ann Surg Oncol. 1998;5(4):376-383. Pubmedid: 9641461.
  • Reintgen D, Cox C, Haddad F, Costello D, Berman C. The role of lymphoscintigraphy in lymphatic mapping for melanoma and breast cancer. J Nucl Med. 1998;39(12):22N-36N. Pubmedid: 9867132.
  • Reintgen D, Haddad F, Pendas S, Berman C, Ku N, Glass F, Messina J, Cox C. Sentinel node biopsy in ductal carcinoma in situ patients. Scientific America Surgery. 1998;12(9):1283-1292. Pubmedid: noPMID.
  • Wells K, Rapaport D, Cruse C, Payne W, Albertini J, Berman C, Lyman G, Reintgen D. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997 Sep;100(3):591-594. Pubmedid: 9283554.
  • Kamath D, Rapaport D, DeConti R, Cruse C, Wells K, Glass L, Messina J, Fenske N, Brobeil A, Berman C, Puleo C, Reintgen D. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. J Fla Med Assoc. 1997 Mar;84(3):182-187. Pubmedid: 9143170.
  • Brobeil A, Kamath D, Cruse CW, Rapaport DP, Wells KE, Shons AR, Messina JL, Glass LF, Berman CG, Puleo CA, Reintgen DS. The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy. J Fla Med Assoc. 1997 Mar;84(3):157-160. Pubmedid: 9143166.
  • Reintgen D, Albertini J, Milliotes G, Marshburn J, Cruse C, Rapaport D, Berman C, Glass L, Fenske N, Einstein, Jr. A, Lyman G. Investment in new technology research can save future health care dollars. J Fla Med Assoc. 1997;84(3):175-181. Pubmedid: 9143169.
  • Schreiber R, Pendas S, Ku N, Reintgen D, Shons A, Berman C, Boulware D, Cox C. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol. 1997;6(1):95-101. Pubmedid: 10030421.
  • Reintgen D, Joseph E, Lyman G, Yeatman T, Balducci L, Ku N, Berman C, Shons A, Wells K, Horton J, Greenberg H, Nicosia S, Clark R, Shivers S, Li W, Wang X, Cantor A, Cox C. The role of selective lymphadenectomy in breast cancer. Cancer Control. 1997;4(3):211-219. Pubmedid: 10763020.
  • Brobeil A, Rapaport D, Wells K, Cruse C, Glass F, Fenske N, Albertini J, Miliotis G, Messina J, DeConti R, Berman C, Shons A, Cantor A, Reintgen D. Multiple primary melanomas: implications for screening and follow-up programs. Ann Surg Oncol. 1997;4:19-23. Pubmedid: 8985513.
  • Ramnath E, Kamath D, Brobeil A, Stall A, Kamath V, Cruse C, Glass F, Messina J, Fenske N, Berman C, Cantor A, Cuthbertson D, Reintgen D, Ross M. Lymphatic mapping for melanoma: long-term results of regional nodal sampling with radioguided surgery. Cancer Control. 1997;4:483-490. Pubmedid: 10763056.
  • Albertini J, Cruse C, Rapaport D, Wells K, DeConti R, Berman C, Jared K, Messina J, Lyman G, Glass L, Fenske N, Reintgen D. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996 Feb;223(2):217-224. Pubmedid: 8597518. Pmcid: PMC1235100.
  • Glass LF, Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, Berman C, Reintgen D, Fenske NA. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg. 1996 Aug;22(8):715-720. Pubmedid: 8780765.
  • Kallergi M, Clarke L, Qian W, Gavrielides M, Venugopal P, Berman C, Holman-Ferris S, Miller M, Clark R. Interpretation of calcifications in screen/film, digitized, and wavelet-enhanced monitor-displayed mammograms: a receiver operating characteristic study. Acad Radiol. 1996 Apr;3(4):285-293. Pubmedid: 8796676.
  • Meliotis G, Albertini J, Berman C, Heller R, Messina J, Glass L, Cruse C, Rapaport D, Puleo C, Fenske N, Petsofglov C, DeConti R, Lyman G. The tumor biology of melanoma nodal metastasis. Am Surg. 1996;62:81-88. Pubmedid: 8540654.
  • Berman C, Choi J. Radioimmunodetection of colorectal carcinoma. Cancer Control. 1996;3(1):48-50. Pubmedid: 10825276.
  • Brobeil A, Berman C, Clark R, Cox C, Reintgen D. Medical-legal pitfalls for the breast surgeon: incomplete mammographic localization of suspicious lesions and the correlation between palpable and mammographic abnormalities. Am Surg. 1996;6:484-487. Pubmedid: 8651534.
  • Glass L, Fenske N, Messina J, Cruse C, Rapaport D, Berman C, Puleo C, Heller R, Miliotes G, Albertini J, Reintgen D. The role of selective lymphadenectomy in the management of patients with malignant melanomoa. Dermatol Surg. 1996;21:979-983.
  • Albertini J, Lyman G, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen D. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. Jama. 1996;276(22):1818-1822. Pubmedid: 8946902.
  • Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, Puleo CA, Heller R, Miliotes G, Albertini J. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatol Surg. 1995 Nov;21(11):979-983. Pubmedid: 7582838.
  • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J, et a. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb;61(2):97-101. Pubmedid: 7856986 .
  • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb;61(2):97-101. Pubmedid: 7856986.
  • Reintgen D, Albertini J, Berman C, Cruse C, Fenske N, Glass L, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. Accurate nodal staging of malignant melanoma. Cancer Control. 1995;2(5):405-414. Pubmedid: 10862181.
  • Phuphanich S, Berman C, Greenberg H, Murtagh F, Prockop L. Thallium-201 SPECT index of radiation necrosis and malignant brain tumor with pathological correlation and survival. J Neuroimaging. 1995;5:68-68. Pubmedid: noPMID.
  • Berman C. The role of lymphoscintigraphy in staging. Cancer Control. 1995;2(5):439-451. Pubmedid: 10862185.
  • Reintgen D, Albertini J, Miliotes G, Berman C, Cruse C, Fenske N, Glasser S, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. The accurate staging and modern day treatment of malignant melanoma. Cancer Res Ther Cont. 1995;4:183-197. Pubmedid: noPMID.
  • Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G. The orderly progression of melanoma nodal metastases. Ann Surg. 1994 Dec;220(6):759-767. Pubmedid: 7986143. Pmcid: PMC1234478.
  • Wells KE, Cruse CW, Daniels S, Berman C, Norman J, Reintgen DS. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg. 1994 Apr;93(4):757-761. Pubmedid: 8134434.
  • Reintgen D, Cruse C, Wells K, Berman C, Fenske N, Glass L, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rapaport D, Seigler H, Balch C. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220(6):759-767.
  • Wells K, Cruse C, Daniels S, Berman C, Norman Jr. J, Reintgen D. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg. 1994;93:757-761.
  • Wang X, Heller R, Cruse C, VanVoorhis N, Glass L, Fenske N, Berman C, Leo-Messina J, Rapaport D, Wells K, DeConti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metasases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994;220:768-774.
  • Brown K, Hazelton T, Parsons A, Fiorica J, Berman C, Silbiger M. PC-based fullcolor composite display in MR imaging of adnexal masses: preliminary clinical application with quantitative image analysis and pathologic correlation. J Comput Assist Tomogr. 1993;17:995-1005.
  • Reintgen D, Cruse C, Schroer K, Glass L, Saba H, Puleo C, King J, Berman C, Hannon L, Cox C. Computer database for melanoma: a clinical management and research tool to ensure continuous quality assessment. Semin Surg Oncol. 1993;9:208-214.
  • Reintgen D, Cruse C, Berman C, Norman Jr. J. A redefinition of skin mapping with the use of lymphoscintigraphy: implications for elective lymph node dissection for melanoma. Melanoma Res. 1993;3:34-34.
  • Berman C, Reintgen D. Radiologic imaging in malignant melanoma: a review. Semin Surg Oncol. 1993;9:232-238.
  • Cox C, Greenberg H, Fleisher D, Clark R, Nicosia S, Berman C, Ku N, Fiorica J, Reintgen D. Natural history and clinical evaluation of the lumpectomy scar. Am Surg. 1993;59:55-59.
  • Reintgen D, Berman C, Cox C, Baekey P, Nicosia S, Greenberg H, Bush C, Lyman G, Clark R. The anatomy of missed breast cancers. Surg Oncol. 1993;2:65-75.
  • Reintgen D, Cox C, Greenberg H, Baekey P, Nicosia S, Berman C, Clark R, Lyman G. The medical legal implications of following mammographic breast masses. Am Surg. 1993;59(2):99-105.
  • Norman Jr. J, Wells K, Kearney R, Cruse C, Berman C, Reintgen D. Identification of lymphatic basins in patients with cutaneous melanoma. Semin Surg Oncol. 1993;9:224-227.
  • Brown H, Hazelton T, Parsons A, Fiorica J, Berman C, Silbiger M. PC-based multiparameter full-color display for tissue segmentation in MRI of adnexal masses. J Comput Assist Tomogr. 1993;17(6):993-1005.
  • Barton DP, Berman C, Cavanagh D, Roberts WS, Hoffman MS, Fiorica JV, Finan MA. Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol Oncol. 1992 Sep;46(3):341-344. Pubmedid: 1526513.
  • Berman CG, Norman J, Cruse CW, Reintgen DS, Clark RA. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg. 1992 Jan;28(1):29-32. Pubmedid: 1642403.
  • Reintgen D, Cruse C, Wells K, Stankard C, Saba H, Schroer K, Cox C, Berman C, Glass L, Alvarez L, Brozena S, Fenske N, Fabri P. The effectiveness of skin cancer screening and continuing education programs toward increasing the survival of patients with malignant melanoma. Surg Oncol. 1992;1:379-384.
  • Heal A, Tyson I, Greenberg H, Balducci L, Ketch R, Tenorio L, Berman C, Silbiger M. Evaluation of multiple infusions (IP) of 131-I-HMFG1 MoAb in ovarian and colorectal carcinoma patients and a nude mouse xenograft with and without IV use of unlabeled MoAb. Antibody Immunoconjugates Radiopharm. 1992;5:86-86.
  • Heal A, Tyson I, Greenberg H, Roberts W, Nicosia S, Berman C, Silbiger M. Pharmacokinetics, dosimetry and clinical evaluation of 131-I-HMFG1 MoAb in the therapy of colorectal and ovarian carcinoma. Antibody Immunoconjugates Radiopharm. 1992;5:1-12.
  • Barton D, Berman C, Cavanagh D, Roberts W, Hoffman M, Fiorica J, Finan M. Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol Oncol. 1992;46:341-344.
  • Berman C, Norman Jr. J, Cruse C, Reintgen D, Clark R. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg. 1992;28(1):29-32.
  • Berman C, Clark R. Diagnostic imaging and cancer. Prim Care. 1992;19:677-713.
  • Norman J, Cruse CW, Espinosa C, Cox C, Berman C, Clark R, Saba H, Wells K, Reintgen D. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg. 1991 Nov;162(5):432-437. Pubmedid: 1951904.
  • Guidera KJ, Einbecker ME, Berman CG, Ogden JA, Arrington JA, Murtagh R. Magnetic resonance imaging evaluation of congenital dislocation of the hips. Clin Orthop Relat Res. 1990 Dec;(261):96-101. Pubmedid: 2245565.
  • Norman J, Wells K, Kearney R, Cruse CW, Berman C, Reintgen D. Identification of lymphatic drainage basins in patients with cutaneous melanoma. Semin Surg Oncol. 9(3):224-227. Pubmedid: 8516608.
  • Messina J, Reintgen D, Cruse C, Rapaport D, Berman C, Fenske N, Glass L. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 4(5):389-395. Pubmedid: 9259965.
  • Joseph E, Messina J, Glass FL, Cruse CW, Rapaport DP, Berman C, Greenberg H, Reintgen DS. Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am. 3(6):341-345. Pubmedid: 9403046.
  • Dauway E, Giuliano R, Haddad F, Pendas S, Costello D, Cox C, Berman C, Ku N, Reintgen D. Lymphatic mapping in breast cancer. In: James M, ed. Hematology/Oncology Clinics of North America:brachytherapy. 13 ed. Philadelphia, PA: W.B. Saunders Company; 1999.
  • Harris E, Lafond G, Arrington J, Berman C, Brodsky N. The head and neck. In: Oncologic Imaging: a clinical perspective. The McGraw Hill Companies; 1998;79-118.
  • Kallergi M, Berman C, Heine J, Hersh M, Hooper L, Kim J, Miller M, Galbo C, Thomas J, Clark R. Effect of default display and presentation protocol on softcopy mammography. In: Digital Mammography IWDM 2002. New York, NY: Springer-Verlag; 2003;202.
  • Berman C, Brodsky N, Clark R. Oncologic Imaging. 2 ed. W.B. Saunders Company; 2002.